One could point out that while funding often depends on social-political factors including age, sex, gender, and race. It's not necessarily a zero sum game either. Not to mention knowlege and technology used to defeat one disease often has applications to other.

Just the fact that Trikafta works probably will spur efforts to do something similar to sickle cell.